rasagiline

Generic: rasagiline

Labeler: teva pharmaceuticals usa, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA AUTHORIZED GENERIC Inactive Finished

Drug Facts

Product Profile

Brand Name rasagiline
Generic Name rasagiline
Labeler teva pharmaceuticals usa, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

rasagiline mesylate .5 mg/1

Manufacturer
Teva Pharmaceuticals USA, Inc.

Identifiers & Regulatory

Product NDC 0093-3060
Product ID 0093-3060_c26cc45d-41aa-456c-8b37-49420366d1f4
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA AUTHORIZED GENERIC
Application Number NDA021641
Listing Expiration 2026-12-31
Marketing Start 2017-01-03

Pharmacologic Class

Classes
monoamine oxidase inhibitor [epc] monoamine oxidase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00933060
Hyphenated Format 0093-3060

Supplemental Identifiers

RxCUI
608328 636664
UNII
LH8C2JI290

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name rasagiline (source: ndc)
Generic Name rasagiline (source: ndc)
Application Number NDA021641 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • .5 mg/1
source: ndc
Packaging
  • 30 TABLET in 1 BOTTLE (0093-3060-56)
source: ndc

Packages (1)

0093-3060-56 30 TABLET in 1 BOTTLE (0093-3060-56)

Ingredients (1)

rasagiline mesylate (.5 mg/1)

Linked Drug Pages (1)

Rasagiline ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "c26cc45d-41aa-456c-8b37-49420366d1f4", "openfda": {"unii": ["LH8C2JI290"], "rxcui": ["608328", "636664"], "spl_set_id": ["e802c83c-e581-4a11-b83d-1df47120078d"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (0093-3060-56)", "package_ndc": "0093-3060-56", "marketing_start_date": "20170103"}], "brand_name": "Rasagiline", "product_id": "0093-3060_c26cc45d-41aa-456c-8b37-49420366d1f4", "dosage_form": "TABLET", "pharm_class": ["Monoamine Oxidase Inhibitor [EPC]", "Monoamine Oxidase Inhibitors [MoA]"], "product_ndc": "0093-3060", "generic_name": "Rasagiline", "labeler_name": "Teva Pharmaceuticals USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Rasagiline", "active_ingredients": [{"name": "RASAGILINE MESYLATE", "strength": ".5 mg/1"}], "application_number": "NDA021641", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20170103", "listing_expiration_date": "20261231"}